| SMS Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532815 |
NSE Symbol : SMSPHARMA |
P/E(TTM) : 53.74 |
|
ISIN Demat : INE812G01025 |
Div & Yield% : - |
EPS(TTM) : 6.67 |
|
Book Value(₹) : 67.39 |
Market Cap(₹Cr) : 3,034.35 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 164.45 | 245.80 | 161.48 | 166.64 | 135.34 | 149.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 164.45 | 245.80 | 161.48 | 166.64 | 135.34 | 149.43 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.37 | 1.65 | 1.49 | 0.81 | 0.51 | 1.26 |
| Total Income | 165.82 | 247.44 | 162.97 | 167.45 | 135.85 | 150.68 |
| Total Expenditure | 130.99 | 212.31 | 132.60 | 138.82 | 108.68 | 126.18 |
| PBIDT | 34.83 | 35.13 | 30.37 | 28.63 | 27.17 | 24.50 |
| Interest | 4.67 | 5.61 | 5.95 | 5.57 | 6.32 | 5.89 |
| PBDT | 30.17 | 29.52 | 24.42 | 23.06 | 20.85 | 18.62 |
| Depreciation | 8.38 | 7.92 | 8.01 | 7.90 | 7.69 | 7.97 |
| Tax | 5.30 | 4.63 | 4.00 | 3.10 | 3.40 | 0.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.16 | 1.06 | 0.24 | 0.01 | 0.47 | 2.51 |
| Reported Profit After Tax | 16.33 | 15.92 | 12.17 | 12.05 | 9.28 | 8.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.33 | 15.92 | 12.17 | 12.05 | 9.28 | 8.07 |
| EPS (Unit Curr.) | 1.93 | 1.88 | 1.44 | 1.42 | 1.10 | 0.95 |
| EPS (Adj) (Unit Curr.) | 1.93 | 1.88 | 1.44 | 1.42 | 1.10 | 0.95 |
| Calculated EPS (Unit Curr.) | 1.93 | 1.88 | 1.44 | 1.42 | 1.10 | 0.95 |
| Calculated EPS (Adj) (Unit Curr.) | 1.93 | 1.88 | 1.44 | 1.42 | 1.10 | 0.95 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.72 | 7.52 | 5.75 | 5.69 | 4.39 | 3.82 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.72 | 7.52 | 5.75 | 5.69 | 4.39 | 3.82 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.47 | 8.47 | 8.47 | 8.47 | 8.47 | 8.47 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.18 | 14.29 | 18.81 | 17.18 | 20.08 | 16.40 |
| PBDTM(%) | 18.35 | 12.01 | 15.12 | 13.84 | 15.41 | 12.46 |
| PATM(%) | 9.93 | 6.48 | 7.54 | 7.23 | 6.86 | 5.40 |